These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Mortality benefits of influenza vaccination in elderly people. Kelly H; Newall AT Lancet Infect Dis; 2008 Aug; 8(8):462-3; author reply 463-5. PubMed ID: 18652991 [No Abstract] [Full Text] [Related]
4. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Simonsen L; Taylor RJ; Viboud C; Miller MA; Jackson LA Lancet Infect Dis; 2007 Oct; 7(10):658-66. PubMed ID: 17897608 [TBL] [Abstract][Full Text] [Related]
5. Using surveillance to evaluate influenza vaccine effectiveness. Jackson LA J Infect Dis; 2009 Jan; 199(2):155-8. PubMed ID: 19086916 [No Abstract] [Full Text] [Related]
7. Influenza vaccine 2008-2009. Med Lett Drugs Ther; 2008 Oct; 50(1296):77-9. PubMed ID: 18833032 [TBL] [Abstract][Full Text] [Related]
8. [The flu of 2012-2013 shows the need to protect at-risk groups of all ages. Vaccination can save lives]. Linde A; Englund H; Hederström P; Nylén G Lakartidningen; 2014 Jan 29-Feb 4; 111(5):150-2. PubMed ID: 24624764 [No Abstract] [Full Text] [Related]
10. Selection bias in evaluating of influenza vaccine effectiveness: a lesson from an observational study of elderly nursing home residents. Fukushima W; Hayashi Y; Mizuno Y; Suzuki K; Kase T; Ohfuji S; Fujieda M; Maeda A; Hirota Y Vaccine; 2008 Nov; 26(50):6466-9. PubMed ID: 18582520 [TBL] [Abstract][Full Text] [Related]
11. Recommended composition of influenza virus vaccines for use in the 2006-2007 influenza season. Wkly Epidemiol Rec; 2006 Mar; 81(9):82-6. PubMed ID: 16671218 [No Abstract] [Full Text] [Related]
12. Seasonal trivalent influenza vaccine for 2010-2011. Med Lett Drugs Ther; 2010 Oct; 52(1348):77-9. PubMed ID: 20885341 [No Abstract] [Full Text] [Related]
13. Efficacy of single versus boost vaccination against influenza virus in patients with multiple myeloma. Hahn M; Schnitzler P; Schweiger B; Kunz C; Ho AD; Goldschmidt H; Schmitt M Haematologica; 2015 Jul; 100(7):e285-8. PubMed ID: 25820335 [No Abstract] [Full Text] [Related]
14. Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant? Skowronski DM; Tweed SA; De Serres G J Infect Dis; 2008 Feb; 197(4):490-502. PubMed ID: 18275271 [TBL] [Abstract][Full Text] [Related]
15. New options for influenza vaccines: quadrivalent, recombinant, and cell culture. Brokhof MM; Foster SL; Hayney MS J Am Pharm Assoc (2003); 2013; 53(5):545-9. PubMed ID: 24030133 [No Abstract] [Full Text] [Related]
16. WHO recommendations on the composition of the 2013/14 influenza virus vaccines in the northern hemisphere. Eurosurveillance editorial team Euro Surveill; 2013 Feb; 18(9):. PubMed ID: 23470023 [No Abstract] [Full Text] [Related]
17. Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case-control study, 2012/13. Valenciano M; Kissling E; Euro Surveill; 2013 Feb; 18(7):3. PubMed ID: 23449183 [TBL] [Abstract][Full Text] [Related]
18. Possible reduced effectiveness of the 2009 H1N1 component of live, attenuated influenza vaccine. Myers CA; Faix DJ; Blair PJ Clin Infect Dis; 2011 Jul; 53(2):207-8. PubMed ID: 21690631 [No Abstract] [Full Text] [Related]